Physician profile
Antonio Drew Schefano
NPI 1700509353
$1,026.43
in general payments reported to CMS, 2019-2025
14 companies · $426 in 2025
The $426 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $197 · 2024: $403 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $295.12 | 2023-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $140.78 | 2023-2025 | Monovisc, Orthovisc, Symphony |
| Vertex Pharmaceuticals Incorporated | $104.80 | 2024-2025 | |
| Amgen INC. | $104.31 | 2023-2025 | Evenity, Krystexxa, Prolia |
| Kerecis Limited | $93.94 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Radius Health, INC. | $66.59 | 2023-2024 | Tymlos |
| C. R. Bard, INC. & Subsidiaries | $51.46 | 2024 | |
| Smith+Nephew, INC. | $39.51 | 2023-2024 | Evos, Trigen Intertan, Journey II |
| Curonix LLC | $34.52 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $23.35 | 2025 | Exogen Ultrasound Bone Healing System |
| Alexion Pharmaceuticals, INC. | $22.67 | 2024 | Strensiq |
| Medtronic, INC. | $18.07 | 2024 | Aquamantys(Tm) |
| Solventum Corporation | $16.70 | 2024 | Prevena, V.A.C.Instill |
| Kci USA, INC. | $14.61 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Schefano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.